Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
Deloitte
McKinsey
Daiichi Sankyo
McKesson
Cantor Fitzgerald
Cerilliant
Fish and Richardson

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR POLIDOCANOL

« Back to Dashboard

Clinical Trials for Polidocanol

Trial ID Title Status Sponsor Phase Summary
NCT00161915 Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices Completed Baxter Healthcare Corporation Phase 3 The purpose of this study was to assess whether endoscopic sclerotherapy with Fibrin Sealant was superior to ligature, with or without Polidocanol, in achieving hemostasis in bleeding esophageal varices and preventing rebleeding. Therapeutic success was defined as survival of the first seven days without clinically significant bleeding.
NCT00377910 The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy Completed Aarhus University Hospital Phase 4 Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
NCT00377910 The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy Completed Northern Orthopaedic Division, Denmark Phase 4 Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
NCT00399451 Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS) Unknown status Liaoyang Central Hospital Phase 1/Phase 2 The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Polidocanol

Condition Name

Condition Name for Polidocanol
Intervention Trials
Varicose Veins 9
Veins, Varicose 1
Epicondylitis 1
Snoring 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Polidocanol
Intervention Trials
Varicose Veins 11
Tendinopathy 2
Cysts 1
Gastroesophageal Reflux 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Polidocanol

Trials by Country

Trials by Country for Polidocanol
Location Trials
United States 38
Germany 2
Brazil 2
United Kingdom 2
Denmark 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Polidocanol
Location Trials
Washington 6
North Carolina 4
California 3
Florida 3
New York 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Polidocanol

Clinical Trial Phase

Clinical Trial Phase for Polidocanol
Clinical Trial Phase Trials
Phase 4 5
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Polidocanol
Clinical Trial Phase Trials
Completed 10
Not yet recruiting 3
Unknown status 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Polidocanol

Sponsor Name

Sponsor Name for Polidocanol
Sponsor Trials
BTG International Inc. 8
UPECLIN HC FM Botucatu Unesp 2
Fundação de Amparo à Pesquisa do Estado de São Paulo 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Polidocanol
Sponsor Trials
Other 21
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Federal Trade Commission
Express Scripts
Merck
Deloitte
US Department of Justice
Fuji
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.